Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Reimagining UHPLC

Published: Thursday, July 17, 2014
Last Updated: Thursday, July 17, 2014
Bookmark and Share
To learn more about the new Vanquish UHPLC system from Thermo Fisher Scientific we spoke to Wulff Niedner, Director of HPLC Product Marketing.

This week saw Thermo Fisher Scientific unveil Vanquish UHPLC, a new high performance liquid chromatography system designed from the ground up. 

Providing new levels of performance, productivity and usability, Thermo Fisher tell us that Vanquish system combines advantages in separations performance, sample throughput, ease-of-use, reproducibility and method transfer efficiency.  

Eager to learn more about this new system we spoke to Wulff Niedner, Director HPLC Product Marketing at Thermo Fisher. 

AB: The Thermo Scientific™ Vanquish™ UHPLC system has been designed from the ground up - was there a feeling that your older systems had gone as far they could?

Wulff Niedner (WN): The existing platform of Thermo Scientific™ UltiMate 3000™ UHPLC systems is very successful and gives chromatographers tremendous capabilities, and they keep performing cutting edge research. But a significant number of customers were seeking additional capabilities. The Vanquish system was designed to set a new benchmark in the industry in a number of ways. Only this completely new industrial design enabled us to effectively host all the innovations we have made for the Vanquish system without compromises. 

AB: How does the performance compare to current systems on the market?

WN: The Vanquish system has been built to be the state-of-the-art UHPLC system allowing users to do more than they could do before. Therefore it has a pressure capability of 1500 bar over the full flow range up to 5 ml/min, which is beyond anything available. The standard sample capacity is twice the industry average with 4 sample racks or well plates, and with the optional Charger module sample capacity can be increased to up to 8832 samples (using 384 well plates). The column compartment offers two thermostatting modes to enable our users to get the maximum resolution from their separation and also give them the ability to perform efficient method transfer when required. The DAD detector, with its new LightPipeTM technology, allows for ultrahigh sensitivity and trace level detection and has a linearity up to 3000 mAU routinely. The system is biocompatible by default, has proprietary technology to ensure robust operation at the benchmark pressure of 1500 bar, and offers integrated modularity; it is not a collection of modules, but appears as an integrated system with modern design, without limiting the flexibility chromatographers need to perform their daily work.

AB: The system is built around the column, is this a new approach for Thermo Fisher, and what benefits does this provide?

WN: In developing the Vanquish system the central paradigm was to provide the users with the best chromatography possible. Excellent chromatography is only achieved when dispersion is minimized and for state-of-the-art UHPLC this is essential. Therefore the column was taken as the central component and the Vanquish system was designed around it. The modular integration gives a clear advantage here over a solely modular approach. Next to that, eliminating accidental void volumes and dispersion effects by a thorough selection of appropriate tubing material and our unique Viper fingertight fitting technology for virtual zero-dead-volume connections even at 1500 bar are additional cornerstones to translate the excellent separation performance of our new Thermo Scientific™ Accucore™ Vanquish C18 UHPLC columns into superb chromatograms. 

AB: How does the system integrate with Thermo Scientific products such as automation and software?

WN: The Vanquish system works perfectly as a standalone system with DAD detection, but also has specific features to accommodate the need to do LC/MS. The column oven can be placed either on the right or on the left side of the system. This ensures the shortest flow path from the UHPLC column to the mass spectrometer is set to minimize dispersion and by that maintain the separation performance in the LC/MS chromatogram.  

The Vanquish system is fully supported by Thermo Scientific™ Dionex™ Chromeleon™ 7.2 CDS, which also supports mass spectrometry. This allows single point software control and the ease for the user of learning only one software package. On top of that, the Vanquish system is also seamlessly integrated into our mass spectrometry software packages.

Finally, the Charger module for sample handling is a great example of how automation is integrated in the Vanquish workflow. Being fully supported by the Chromeleon software, our customers can not only build up a sample pipeline that holds and processes more than 8,000 samples, but managing even these huge sample sets is done in a few mouse-clicks thanks to the Operational SimplicityTM feature of our gold-standard Chromatography Data System.

AB: Beyond the advancements in performance you also describe benefits of clean design. Can you tell me more about these and how they were identified?  

WN: “Form follows function” is a very basic but comprehensive principle in architecture and design. We kept this in mind from the beginning when we started to discuss our new generation UHPLC. The result is the completely new industrial design of the Vanquish system providing new levels of performance, productivity and usability without compromising flexibility. One obvious example how design supports functionality are the doors: they open widely to allow perfect access for setting up fluidic connections, but when closed there is a nice clean appearance. Or there are no simple status LED indicators, but LED bars that visualize the relevant information on instrument status. And under the hood, the design story continues: The idea of a lean design is applied also to the inside of the system; flow path fluidics are very straightforward, as are other likeliness for solvent waste lines, and the integrated, self-aligning drainage system. Details like a drawer for consumables and drawer-accessible Vanquish modules make maintenance easy to perform. 

The new overall appearance of the Vanquish system matches also well with our latest generation of Thermo Scientific mass spectrometers.

Chromatographers who are interested to know more about the system are invited to go through a virtual demo or to contact us to see and experience the Vanquish system in one of our demo labs. Both available through our website on thermoscientific.com/vanquish.

Wulff Niedner was speaking to Ashley Board, Managing Editor for Technology Networks. You can find Ashley on  and follow Technology Networks on Twitter.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Thermo Launches Geneticon
Thermo Fisher Scientific launches GenetiCon, a virtual resource showcasing the real-life science behind superheroic powers and more.
Tuesday, July 07, 2015
Thermo Fisher Agrees to Buy Alfa Aesar for $403M
The company announced a definitive agreement to buy the research chemical manufacturer for $403 million.
Friday, June 26, 2015
Ebola Sequencing Data Released to Global Research Community Online
To curb further spread of Ebola in Sierra Leone, a team of scientists that is part of an international, multi-organizational effort has released their first dataset of the virus’ genetic structure online.
Wednesday, June 03, 2015
Thermo's NGS Platform Selected for Nationwide Clinical Research Program
National Cancer Institute-MATCH trial to sequence thousands of tumor samples using Ion Torrent targeted sequencing technology.
Monday, June 01, 2015
Thermo Strengthens Bioprocessing Offering with Advanced Scientifics Acquisition
Thermo Fisher Scientific has acquired Advanced Scientifics, Inc., a global provider of single-use technologies for customized bioprocessing solutions, for $300 million in cash.
Friday, February 06, 2015
Thermo Fisher Q3 Revenues up 31 Percent
Thermo Fisher announced that revenues grew 31% to $4.17 billion for the third quarter ended September 27, 2014.
Thursday, October 23, 2014
Thermo Scientific Announces Listing of the Ion PGM Dx System
Company has completed the listing with the U.S. FDA as class II medical device.
Saturday, September 20, 2014
Thermo Fisher, NRLs Team to Confirm Dioxins in Feed and Food
Thermo Fisher Scientific worked closely with national reference labs (NRLs) in the European Union to support the development of new regulation.
Monday, September 08, 2014
Thermo Completes Sale of Cole-Parmer to GTCR
Thermo Fisher Scientific Inc. announced that it has completed the sale of its Cole-Parmer customer channel business to private equity firm GTCR LLC for approximately $480 million in cash.
Wednesday, August 20, 2014
Thermo Supports Distinguished Analytical Chemistry Seminar Series at NC State
An endowment established by the company provides opportunities to attend presentations by leading analytical chemistry authorities.
Tuesday, August 19, 2014
NSF International Expands Use of Thermo Scientific Watson LIMS
NSF International implements Thermo Scientific Watson LIMS to support bioanalytical testing for both clinical and non-clinical research studies at Bristol, CT laboratory.
Saturday, August 09, 2014
Thermo, NewLab Sign Forensic Sample Processing Distribution Agreement
Under the agreement, Thermo Fisher is the sole distributor and servicing agent of the CPA300™ and CPA200™ card processing instruments.
Friday, July 25, 2014
Thermo to Sell Cole-Parmer for $480M
Company has signed a definitive agreement to sell its Cole-Parmer channel business to private equity firm GTCR, LLC for $480 million in cash.
Monday, July 21, 2014
ATCC, CDC and Thermo Partner on Public Health RT-PCR Assay
New technology supports HIV-1 drug resistance surveillance in resource-limited countries.
Wednesday, June 25, 2014
Thermo Registers San Jose Facility with FDA
The site has established a quality system in accordance with the FDA Quality System Regulations to design and manufacture devices for analyzing samples from patients for in vitro diagnostic use.
Monday, June 16, 2014
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!